UCLA’s Tiny Tumor ‘Farm’ Lets AI Speed-Test Cancer Drugs
UCLA published a step‑by‑step protocol and open code for an AI‑assisted platform that tracks drug responses in thousands of bioprinted tumor organoids. The methods aim to speed functional testing and move personalized therapy screening closer to clinical use.












